Article Details

Nilo Therapeutics: $101 Million Series A Raised For Advancing Neuro-Immunology Drug Platform

Retrieved on: 2025-10-13 18:15:36

Tags for this article:

Click the tags to see associated articles and topics

Nilo Therapeutics: $101 Million Series A Raised For Advancing Neuro-Immunology Drug Platform. View article details on hiswai:

Excerpt

... by The Column Group (TCG), DCVC Bio, and Lux Capital, with additional support from the Gates Foundation and Alexandria Venture Investments.

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo